These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Cell therapy in chronic liver disease. Nicolas CT; Wang Y; Nyberg SL Curr Opin Gastroenterol; 2016 May; 32(3):189-94. PubMed ID: 26950359 [TBL] [Abstract][Full Text] [Related]
13. The Use of Induced Pluripotent Stem Cells for the Study and Treatment of Liver Diseases. Hansel MC; Davila JC; Vosough M; Gramignoli R; Skvorak KJ; Dorko K; Marongiu F; Blake W; Strom SC Curr Protoc Toxicol; 2016 Feb; 67():14.13.1-14.13.27. PubMed ID: 26828329 [TBL] [Abstract][Full Text] [Related]
14. Stem Cell-Based Therapies for Liver Diseases: An Overview and Update. Wang J; Sun M; Liu W; Li Y; Li M Tissue Eng Regen Med; 2019 Apr; 16(2):107-118. PubMed ID: 30989038 [TBL] [Abstract][Full Text] [Related]
15. Present and Future Perspectives of Using Human-Induced Pluripotent Stem Cells and Organoid Against Liver Failure. Kuse Y; Taniguchi H Cell Transplant; 2019 Dec; 28(1_suppl):160S-165S. PubMed ID: 31838891 [TBL] [Abstract][Full Text] [Related]
17. Generation of Human Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cells for Cellular Medicine. Deguchi S; Takayama K; Mizuguchi H Biol Pharm Bull; 2020; 43(4):608-615. PubMed ID: 32238703 [TBL] [Abstract][Full Text] [Related]
18. Evolving Cell-Based and Cell-Free Clinical Strategies for Treating Severe Human Liver Diseases. Cernigliaro V; Peluso R; Zedda B; Silengo L; Tolosano E; Pellicano R; Altruda F; Fagoonee S Cells; 2020 Feb; 9(2):. PubMed ID: 32046114 [TBL] [Abstract][Full Text] [Related]
19. The quest for liver progenitor cells: a practical point of view. Dollé L; Best J; Mei J; Al Battah F; Reynaert H; van Grunsven LA; Geerts A J Hepatol; 2010 Jan; 52(1):117-29. PubMed ID: 19913937 [TBL] [Abstract][Full Text] [Related]